Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Inducing T cell dysfunction by chronic stimulation of CAR-engineered T cells targeting cancer cells in suspension cultures

STAR Protocols(2023)10.1016/j.xpro.2022.101954Source: DataRank Database

Inducing T cell dysfunction by chronic stimulation of CAR-engineered T cells targeting cancer cells in suspension cultures is a research paper published in STAR Protocols (2023). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.51)OA: goldTopics (33)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Jack H. Landmann ORCID,Corvin D. Arveseth ORCID,Nathan Singh ORCID,Mehmet Emrah Selli ORCID

Live enrichment

PubMed:36607811 PMC:PMC9826863 OpenAlex:https://openalex.org/W4313598148

National Institutes of Health

Grant: K08CA234470

University of Pennsylvania

American Association of Immunologists

Damon Runyon Cancer Research Foundation

Gabrielle's Angel Foundation for Cancer Research

FWCI

2.51

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://ars.els-cdn.com/content/image/1-s2.0-S2666166722008346-fx1_lrg.jpg

GOLDhttps://doi.org/10.1016/j.xpro.2022.101954

publisherhttps://ars.els-cdn.com/content/image/1-s2.0-S2666166722008346-fx1_lrg.jpg

publisherhttps://api.elsevier.com/content/article/PII:S2666166722008346?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666166722008346?httpAccept=text/plain

Fields of Study

CAR-T cell therapy researchViral Infectious Diseases and Gene Expression in InsectsNanowire Synthesis and ApplicationsMedicineReceptors, Antigen, T-CellT-LymphocytesImmunotherapy, AdoptiveReceptors, Chimeric AntigenImmunologic TestsNeoplasms

MeSH Terms

Receptors, Chimeric AntigenImmunologic TestsNeoplasmsReceptors, Antigen, T-CellT-LymphocytesImmunotherapy, Adoptive

Keywords

StimulationChimeric antigen receptorCell cultureCancer researchCancerCancer cellAntigenMedicineT cellImmunologyBiologyCell biologyNeuroscienceInternal medicineImmune systemGeneticsBiotechnology And Bioengineering

Sustainable Development Goals

SDG 0: Good health and well-being